Healthtech Startups

Hylomorph is a medical device company developing Vesta, a product in the cardiac/implantable device area, working with clinical partners such as Penn Medicine, Sant'Orsola Hospital, and the German Heart Center Charité. The company is headquartered at Technopark Zurich.

2 investors

Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.

2 investors

Hypherdata operates an e-auction marketplace platform that connects pharmaceutical companies and AI/ML developers with healthcare data providers to procure real-world medical datasets for clinical research, drug development, and AI model training. The platform facilitates competitive bidding for datasets across multiple medical specialties and imaging modalities, including data cleaning, annotation, and privacy compliance services.

2 investors

Hyris provides diagnostic testing solutions and marketplace technology for healthcare facilities and agricultural operations, enabling distributed testing networks managed from a central hub and pathogen detection services.

2 investors

2 investors

IASO Therapeutics develops synthetic antigen vaccines using a mutant Qβ virus-like particle carrier platform to generate targeted, durable immunity. The company focuses on next-generation vaccines for infectious disease prevention, including combating antimicrobial resistance.

2 investors

Icarus Medical builds custom-fit knee, leg, and ankle braces using a proprietary scan-to-fabrication process, including offloading knee braces that reduce weight on the joint to relieve pain from cartilage damage. Its products serve people with knee pain, instability, post-op recovery needs, and sports use, and are made in the USA.

2 investors

iContracts, part of Medispend, offers the Revenue Management Suite (RMS), an enterprise platform managing the contract-to-cash lifecycle for pharmaceutical manufacturers, covering chargebacks, rebates, government pricing, and Gross-to-Net forecasting. It also provides government compliance tools, analytics, and professional services for finance, compliance, and commercial teams in the life sciences industry.

2 investors

iCorNet develops a tailored cardiac remodeling prevention net using 3D cardiac imaging and computer-controlled knitting technology to treat dilated cardiomyopathy. The device is designed for heart failure patients who do not respond adequately to drug therapy and cannot access cardiac transplantation.

2 investors

Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.

2 investors

iDentalSoft is a cloud-based dental practice management software that consolidates billing, patient communication, business communication, and workflow analytics into one system. It serves dental practices of all sizes, including solo offices, multi-location groups, and community healthcare and FQHC clinics in the United States.

2 investors

IDEV Technologies was a Webster, Texas-based medical device company developing devices for interventional radiologists, vascular surgeons, and cardiologists, notably the Supera Veritas nitinol stent for peripheral artery disease.

2 investors

IDEXX develops diagnostic and software products for veterinary clinics, livestock and dairy operations, and water quality testing. The company serves the global animal health, food safety, and public health sectors with point-of-care and laboratory diagnostic solutions.

2 investors

Idience is a biopharmaceutical company focused on developing and commercializing new medicines. Established in 2019 as a wholly owned subsidiary of Korean pharmaceutical group Ildong Holdings.

2 investors

IDUN Technologies develops brain-computer interface devices that collect and process cognitive and emotional data to promote wellbeing. The company serves research institutions and commercial partners applying neurotechnology for observation, diagnosis, intervention, and wellness applications.

2 investors

ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. Its focus is on drug candidates with differentiated clinical profiles.

2 investors

Ikerian applies data and AI to identify biomarkers linked to chronic and systemic disorders, aggregate clinical insights, and support treatment decisions. The company serves healthcare stakeholders and drug developers by curating information and optimizing clinical workflows and operations.

2 investors

ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.

2 investors

Illume Labs aggregates data from wearables, blood tests, and genomic sequencing to deliver personalized health insights via text message and conversational AI, helping users understand changes in their health metrics and receive actionable recommendations.

2 investors

Illumi Medical is a medical device company based in Japan with research facilities in Nagoya and Koriyama. The page provides company contact and location information but does not specify the company's product offerings or business focus.

2 investors

Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health. The firm provides capital, sequencing access, mentorship, and lab capabilities to portfolio companies through its Labs program.

2 investors

Illuminate provides a Multi-Tiered System of Supports (MTSS) management solution that helps K-12 schools identify universal student needs, track interventions, and monitor progress using data-driven assessments. The platform supports decision-making across all three tiers of intervention by integrating academic and social-emotional behavior screening, progress monitoring, and collaborative meeting tools.

2 investors

Iluria develops technology to analyze and help manage ADHD in children, aiming to improve quality of life for those children and their parents. It provides ADHD analysis intended to reduce trial-and-error in treatment.

2 investors

ImageMover offers software that captures photos of COVID-19 test kit results and links them to the test subject along with demographic data, then stores the images in health system archives, EHRs, or regional and work-related databases. The tool is aimed at health systems needing documented records of rapid test results.

2 investors